CLIP2 as radiation biomarker in papillary thyroid carcinoma

被引:40
|
作者
Selmansberger, M. [1 ]
Feuchtinger, A. [2 ]
Zurnadzhy, L. [3 ]
Michna, A. [1 ]
Kaiser, J. C. [4 ]
Abend, M. [5 ]
Brenner, A. [6 ]
Bogdanova, T. [3 ]
Walch, A. [2 ]
Unger, K. [1 ,7 ]
Zitzelsberger, H. [1 ,7 ]
Hess, J. [1 ,7 ]
机构
[1] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Radiat Cytogenet, D-85764 Neuherberg, Germany
[2] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, D-85764 Neuherberg, Germany
[3] Natl Acad Med Sci Ukraine, Inst Endocrinol & Metab, Kiev, Ukraine
[4] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany
[5] Bundeswehr Inst Radiobiol, Munich, Germany
[6] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[7] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Clin Cooperat Grp Personalized Radiotherapy Head, D-85764 Neuherberg, Germany
关键词
INDUCED GENOMIC INSTABILITY; IONIZING-RADIATION; CHERNOBYL ACCIDENT; CANCER; PROTEIN; REARRANGEMENTS; EXPOSURE; KINESIN; RET/PTC; DYNEIN;
D O I
10.1038/onc.2014.311
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A substantial increase in papillary thyroid carcinoma (PTC) among children exposed to the radioiodine fallout has been one of the main consequences of the Chernobyl reactor accident. Recently, the investigation of PTCs from a cohort of young patients exposed to the post-Chernobyl radioiodine fallout at very young age and a matched nonexposed control group revealed a radiation-specific DNA copy number gain on chromosomal band 7q11.23 and the radiation-associated mRNA overexpression of CLIP2. In this study, we investigated the potential role of CLIP2 as a radiation marker to be used for the individual classification of PTCs into CLIP2-positive and - negative cases-a prerequisite for the integration of CLIP2 into epidemiological modelling of the risk of radiation-induced PTC. We were able to validate the radiation-associated CLIP2 overexpression at the protein level by immunohistochemistry (IHC) followed by relative quantification using digital image analysis software (P = 0.0149). Furthermore, we developed a standardized workflow for the determination of CLIP2-positive and - negative cases that combines visual CLIP2 IHC scoring and CLIP2 genomic copy number status. In addition to the discovery cohort (n = 33), two independent validation cohorts of PTCs (n = 115) were investigated. High sensitivity and specificity rates for all three investigated cohorts were obtained, demonstrating robustness of the developed workflow. To analyse the function of CLIP2 in radiation-associated PTC, the CLIP2 gene regulatory network was reconstructed using global mRNA expression data from PTC patient samples. The genes comprising the first neighbourhood of CLIP2 (BAG2, CHST3, KIF3C, NEURL1, PPIL3 and RGS4) suggest the involvement of CLIP2 in the fundamental carcinogenic processes including apoptosis, mitogen-activated protein kinase signalling and genomic instability. In our study, we successfully developed and independently validated a workflow for the typing of PTC clinical samples into CLIP2-positive and CLIP2-negative and provided first insights into the CLIP2 interactome in the context of radiation-associated PTC.
引用
收藏
页码:3917 / 3925
页数:9
相关论文
共 50 条
  • [21] PAPILLARY CARCINOMA OF THYROID
    WUESTER, WO
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 160 (14): : 1269 - 1269
  • [22] COINCIDENTAL PAPILLARY CARCINOMA OF THE THYROID IN 2 SISTERS
    SZANTO, J
    GUNDY, C
    TOTH, K
    KASLER, M
    ONCOLOGY, 1990, 47 (01) : 92 - 94
  • [23] PAPILLARY CARCINOMA OF THYROID
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 160 (01): : 89 - 89
  • [24] PAPILLARY CARCINOMA OF THE THYROID
    SEGAL, K
    FRIDENTAL, R
    LUBIN, E
    SHVERO, J
    SULKES, J
    FEINMESSER, R
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1995, 113 (04) : 356 - 363
  • [25] X-ray crystal structure of HLA-DQ2 in complex with CLIP1 and CLIP2
    Thanh Binh Nguyen
    Jayaraman, Priya
    Bergseng, Elin
    Madhusudhan, Mallur Srivatsan
    Sollid, Ludvig M.
    Kim, Chu-Young
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [26] TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
    Jianlin Zhang
    Xumin Zhou
    Fan Yao
    JiaLi Zhang
    Qiang Li
    Cancer Cell International, 24
  • [27] A Potential Biomarker of Serum Matrix Metalloproteinase-11 for Papillary Thyroid Carcinoma
    Wang, Xiaodong
    Liu, Lina
    Li, Guohua
    Li, Chunxiang
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2020, 10 (10) : 1452 - 1456
  • [28] Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
    Hong, Shubin
    Lin, Bo
    Xu, Minjie
    Zhang, Quan
    Huo, Zijun
    Su, Mingyang
    Ma, Chengcheng
    Liang, Jinyu
    Yu, Shuang
    He, Qiye
    Su, Zhixi
    Li, Yanbing
    Liu, Rui
    Guo, Zhuming
    Lv, Weiming
    Xiao, Haipeng
    EBIOMEDICINE, 2023, 90
  • [29] Imaging Mass Spectrometry in Papillary Thyroid Carcinoma for the Identification and Validation of Biomarker Proteins
    Min, Kyueng-Whan
    Bang, Joo-Young
    Kim, Kwang Pyo
    Kim, Wan-Seop
    Lee, Sang Hwa
    Shanta, Selina Rahman
    Lee, Jeong Hwa
    Hong, Ji Hye
    Lim, So Dug
    Yoo, Young-Bum
    Na, Chan-Hyun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (07) : 934 - +
  • [30] Evaluation of ITGA3 as a Biomarker of Progression and Recurrence in Papillary Thyroid Carcinoma
    Zhang, Guoliang
    Li, Bing
    Lin, Yuanmei
    FRONTIERS IN ONCOLOGY, 2022, 11